drugset / Trial / NCT07187193

Efficacy and Safety of Low-Dose Cytarabine Combined With Thalidomide in Adult Patients With Untreated LCH

NCT07187193

NaSingle-groupOpen-labelTreatment

Summary

Treatment of Adult Patients with Newly Diagnosed Langerhans Cell Histiocytosis (LCH) Using a Low-Dose Cytarabine Combined with Thalidomide Regimen.

Timeline

Start
2025-04-12
Primary completion
2027-04-12
Completion
2027-04-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Cytarabine Small molecule 100 mg/m2
Subject Thalidomide Other / unclassified 100 mg